Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Centrin-2 is required for centriole duplication in mammalian cells.
Salisbury JL, Suino KM, Busby R, Springett M. Salisbury JL, et al. Curr Biol. 2002 Aug 6;12(15):1287-92. doi: 10.1016/s0960-9822(02)01019-9. Curr Biol. 2002. PMID: 12176356
Impaired p53 function leads to centrosome amplification, acquired ERalpha phenotypic heterogeneity and distant metastases in breast cancer MCF-7 xenografts.
D'Assoro AB, Busby R, Acu ID, Quatraro C, Reinholz MM, Farrugia DJ, Schroeder MA, Allen C, Stivala F, Galanis E, Salisbury JL. D'Assoro AB, et al. Oncogene. 2008 Jun 26;27(28):3901-11. doi: 10.1038/onc.2008.18. Epub 2008 Feb 11. Oncogene. 2008. PMID: 18264135 Free PMC article.
Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint.
D'Assoro AB, Busby R, Suino K, Delva E, Almodovar-Mercado GJ, Johnson H, Folk C, Farrugia DJ, Vasile V, Stivala F, Salisbury JL. D'Assoro AB, et al. Oncogene. 2004 May 20;23(23):4068-75. doi: 10.1038/sj.onc.1207568. Oncogene. 2004. PMID: 15064746
Amplified centrosomes in breast cancer: a potential indicator of tumor aggressiveness.
D'Assoro AB, Barrett SL, Folk C, Negron VC, Boeneman K, Busby R, Whitehead C, Stivala F, Lingle WL, Salisbury JL. D'Assoro AB, et al. Breast Cancer Res Treat. 2002 Sep;75(1):25-34. doi: 10.1023/a:1016550619925. Breast Cancer Res Treat. 2002. PMID: 12500932
Characterization of the X-linked murine centrin Cetn2 gene.
Hart PE, Poynter GM, Whitehead CM, Orth JD, Glantz JN, Busby RC, Barrett SL, Salisbury JL. Hart PE, et al. Gene. 2001 Feb 21;264(2):205-13. doi: 10.1016/s0378-1119(01)00342-0. Gene. 2001. PMID: 11250075
CCN1, a candidate target for zoledronic acid treatment in breast cancer.
Espinoza I, Liu H, Busby R, Lupu R. Espinoza I, et al. Mol Cancer Ther. 2011 May;10(5):732-41. doi: 10.1158/1535-7163.MCT-10-0836. Epub 2011 Mar 10. Mol Cancer Ther. 2011. PMID: 21393426 Free PMC article.
Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts.
Khurana A, Jung-Beom D, He X, Kim SH, Busby RC, Lorenzon L, Villa M, Baldi A, Molina J, Goetz MP, Shridhar V. Khurana A, et al. Among authors: busby rc. Clin Exp Metastasis. 2013 Apr;30(4):407-15. doi: 10.1007/s10585-012-9546-5. Epub 2013 Feb 15. Clin Exp Metastasis. 2013. PMID: 23412907 Free PMC article.
Metal accumulation capacity in indigenous Alaska vegetation growing on military training lands.
Busby RR, Douglas TA, LeMonte JJ, Ringelberg DB, Indest KJ. Busby RR, et al. Int J Phytoremediation. 2020;22(3):259-266. doi: 10.1080/15226514.2019.1658708. Epub 2019 Sep 3. Int J Phytoremediation. 2020. PMID: 31478391
Ecotoxicity of 2,4-dinitrotoluene to cold tolerant plant species in a sub-Arctic soil.
Doherty SJ, Messan KS, Busby RR, Barbato RA. Doherty SJ, et al. Among authors: busby rr. Int J Phytoremediation. 2019;21(10):958-968. doi: 10.1080/15226514.2019.1583720. Epub 2019 Apr 24. Int J Phytoremediation. 2019. PMID: 31016985
The Race: Quality Assurance Performance Improvement Project Aimed at Achieving Superior Patient Outcomes.
Tidwell J, Busby R, Lewis B, Falder K, Langston A, Allen SS, Foglia DC. Tidwell J, et al. Among authors: busby r. J Nurs Care Qual. 2016 Apr-Jun;31(2):99-104. doi: 10.1097/NCQ.0000000000000166. J Nurs Care Qual. 2016. PMID: 26599508 No abstract available.
46 results
Jump to page